Antithrombotic treatment and stroke severity in patients with atrial fibrillation
Natan M Bornstein* and Eitan Auriel
Correspondence *Department of Neurology, Tel Aviv Sourasky Medical Center, 6 Weizmann St, 64239 Tel Aviv, Israel
Email strokeun@tasmc.health.gov.il
This article has no abstract so we have provided the first paragraph of the full text.
AF is the most common cardiac arrhythmia—affecting more than two million people in the US1—and an important independent risk factor for ischemic stroke.2 Anticoagulation therapy with adjusted-dose warfarin has been shown to reduce the risk of stroke in patients with AF by about 40%, relative to aspirin, regardless of whether the stroke is primary or secondary.3 The effects of warfarin treatment on stroke severity and mortality among patients with AF are, however, less clear.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Thrombi?beware of red cells bearing giftsNature Biotechnology News and Views (01 Aug 2003)
